APVO icon

Aptevo Therapeutics
APVO

Overview Fund Activity

12 hedge funds and large institutions have $14.8M invested in Aptevo Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

Holders
12
Holders Change
+4
Holders Change %
+50%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
–
Closed
3
Calls
$675K
Puts
–
Net Calls
+$675K
Net Calls Change
+$675K

Top Buyers

1
SCM
1
Stonepine Capital Management
Oregon
$3.51M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.98M
3
PWAM
3
Park West Asset Management
California
$900K
4
CH
4
CVI Holdings
Delaware
$703K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$631K

Top Sellers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$138K
2
Deutsche Bank
2
Deutsche Bank
Germany
$64K
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$0
4
SIM
4
Spark Investment Management
New York
$123K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$102K
Name Holding Trade Value Shares
Change 		Shares
Change %
Macquarie Group
51
Macquarie Group
Australia
– -$12K – –
Wells Fargo
52
Wells Fargo
California
– -$8K – –
SEI Investments
53
SEI Investments
Pennsylvania
– -$54K – –
Fidelity Investments
54
Fidelity Investments
Massachusetts
– -$1K – –
HS
55
HighVista Strategies
Massachusetts
– -$101K – –
Morgan Stanley
56
Morgan Stanley
New York
– -$1K – –
1 2
3